Literature DB >> 6691487

Correlation between the dexamethasone suppression test in depressed patients and clinical response.

C B Nemeroff, D L Evans.   

Abstract

Eighteen psychiatric inpatients who fulfilled DSM-III criteria for major depression and who had a positive dexamethasone suppression test after admission were later retested. Of the 13 patients who exhibited cortisol suppression at discharge, two relapsed within 6 months; five remained nonsuppressors at discharge, and all either required further inpatient care or were symptomatic within 2 weeks to 4 months. Continued cortisol nonsuppression was thus associated with poor clinical response or high risk of relapse.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6691487     DOI: 10.1176/ajp.141.2.247

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  4 in total

Review 1.  Partial remission, residual symptoms, and relapse in depression.

Authors:  E S Paykel
Journal:  Dialogues Clin Neurosci       Date:  2008       Impact factor: 5.986

2.  PACAP-deficient mice show attenuated corticosterone secretion and fail to develop depressive behavior during chronic social defeat stress.

Authors:  Michael L Lehmann; Tomris Mustafa; Adrian M Eiden; Miles Herkenham; Lee E Eiden
Journal:  Psychoneuroendocrinology       Date:  2012-10-11       Impact factor: 4.905

3.  Season of birth, clinical manifestations and Dexamethasone Suppression Test in unipolar major depression.

Authors:  Konstantinos N Fountoulakis; Apostolos Iacovides; Michael Karamouzis; George S Kaprinis; Charalambos Ierodiakonou
Journal:  Ann Gen Psychiatry       Date:  2007-08-03       Impact factor: 3.455

4.  Stress hormone response to the DEX-CRH test and its relation to psychotherapy outcome in panic disorder patients with and without agoraphobia.

Authors:  Susann Wichmann; Stefan R Bornstein; Thomas Lorenz; Katja Petrowski
Journal:  Transl Psychiatry       Date:  2018-02-02       Impact factor: 6.222

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.